Core Viewpoint - The public fund market is currently experiencing two significant trends: a surge in limit purchases for high-performing active equity funds and a wave of self-purchases by public fund institutions to bolster market confidence [2][8]. Limit Purchases - Numerous high-performing active equity funds have announced limits on purchases, with over a hundred funds implementing such measures since the beginning of the second half of the year [2][5]. - For instance, China Europe Fund announced limits on large purchases for its medical innovation stock fund and other funds, citing the need to ensure stable operations and protect the interests of existing fund holders [4][5]. - The performance of these funds has been impressive, with some, like the China Europe Medical Innovation Stock Fund, achieving over 60% net value growth year-to-date [5][6]. Self-Purchases - Public fund institutions, including Southern Fund and Industrial Bank of China Credit Fund, have initiated significant self-purchases of their equity funds, with Southern Fund planning to invest at least 230 million yuan [7][8]. - This self-purchase trend is seen as a positive signal, indicating that institutions remain optimistic about the market's future, especially as the Shanghai Composite Index stabilizes above 3600 points [8]. - The self-purchases not only serve as a confidence endorsement but also create a deeper capital bond between the institutions and their funds, promoting a long-term investment philosophy [8].

Core Viewpoint - The A-share market is recovering, with the Shanghai Composite Index stabilizing above 3600 points, leading to two significant trends in the public fund market: many high-performing active equity funds are imposing purchase limits, and public institutions are actively buying back their funds to boost market confidence [2][8]. Fund Purchase Limits - Over a hundred active equity funds have announced purchase suspensions or limits since the beginning of the second half of the year, particularly those with strong performance and significant growth in scale during the first half [2][4]. - For instance, China Europe Fund announced limits on large purchases for several of its funds, including a cap of 100,000 yuan for the China Europe Medical Innovation Stock Fund and 1 million yuan for the China Europe Science and Technology Theme Mixed Fund [3][4]. - The rationale behind these limits is to ensure stable fund operations and protect the interests of existing fund holders, reflecting a cautious operational strategy among fund managers [3][5]. Fund Performance and Growth - The China Europe Medical Innovation Stock Fund has seen a net value increase of over 60% year-to-date, with its scale growing to 8.114 billion yuan by the end of Q2, an increase of approximately 931 million yuan from the end of last year [4]. - Other funds, such as the China Europe Science and Technology Theme Mixed Fund and the China Europe Digital Economy Mixed Fund, have also experienced significant growth, with year-to-date net value increases exceeding 30% and 60%, respectively [4]. - The trend of limiting purchases is seen as a way to prevent strategy failure due to excessive scale and to maintain existing investors' returns [5]. Self-Purchase by Public Institutions - Several public institutions, including Southern Fund and Industrial Bank of China Credit Fund, have initiated a wave of self-purchases, indicating confidence in the long-term stability and health of the capital market [6][8]. - Southern Fund plans to invest at least 230 million yuan in its equity funds, committing to hold these investments for at least one year [6][7]. - This self-purchase activity is viewed as a positive signal, suggesting that institutions remain optimistic about the market's future, especially as the index surpasses 3600 points [8]. Strategic Shifts in the Fund Industry - The public fund industry is undergoing two strategic transformations: shifting from a "scale-oriented" approach to a "quality-driven" model, and deepening the investment philosophy towards "long-termism" [8]. - The imposition of purchase limits by high-performing funds reflects a commitment to maintaining the integrity of investment strategies and ensuring effective execution [5][8]. - Self-purchases by fund companies not only serve as a confidence endorsement but also create a capital link that binds interests, fostering a positive development ecosystem within the industry [8].

Core Insights - The public fund management scale has reached a new historical high of 34.05 trillion yuan as of the end of Q2 2025, with a quarterly increase of over 2.24 trillion yuan [1][2] - The main contributors to this growth are bond funds, money market funds, and equity funds, with bond funds increasing by 865.32 billion yuan, money market funds by 950.54 billion yuan, and equity funds by 271.15 billion yuan [2] Fund Management Scale - As of the end of Q2 2025, the management scale of various fund types includes: equity funds at 4.74 trillion yuan, mixed funds at 3.32 trillion yuan, bond funds at 10.77 trillion yuan, and money market funds at 13.93 trillion yuan [1] - The public fund management scale has consistently increased since surpassing 30 trillion yuan in April 2024, with multiple records set thereafter [1] Leading Fund Companies - The top ten public fund management companies include E Fund, Huaxia Fund, and GF Fund, with E Fund managing 2.16 trillion yuan and Huaxia Fund managing 2.10 trillion yuan, marking them as the only two companies above the 2 trillion yuan threshold [2][3] - Huaxia Fund experienced the largest growth in management scale in Q2, increasing by 184.76 billion yuan [2] Non-Money Market Fund Growth - In the non-money market fund category, the top ten companies include E Fund, Huaxia Fund, and GF Fund, with both Huaxia and E Fund seeing increases of over 100 billion yuan in management scale [3] - Several thematic funds have also seen significant growth, particularly index funds, driven by large capital inflows into broad-based index ETFs [3][4] Thematic Fund Performance - Among actively managed equity funds, thematic funds have shown substantial growth, with the highest increase seen in the Huatai-PineBridge Innovation Medicine Mixed Fund, which grew by 4.36 billion yuan [4] - Other notable funds include Huaxia Military Industry Security Mixed Fund and Yongying Advanced Manufacturing Select Mixed Fund, both of which also experienced significant scale increases [4]